301122 Stock Overview
Engages in the research, development, production, and sale of injection needles, syringes and other related medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Caina Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥19.22 |
| 52 Week High | CN¥44.20 |
| 52 Week Low | CN¥18.31 |
| Beta | 0.66 |
| 11 Month Change | -14.04% |
| 3 Month Change | -27.44% |
| 1 Year Change | -48.28% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -51.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301122 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 3.9% | -1.7% | 0.4% |
| 1Y | -48.3% | -19.3% | -17.8% |
Return vs Industry: 301122 underperformed the CN Medical Equipment industry which returned -19.3% over the past year.
Return vs Market: 301122 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
| 301122 volatility | |
|---|---|
| 301122 Average Weekly Movement | 7.4% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 301122's share price has been volatile over the past 3 months.
Volatility Over Time: 301122's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 689 | Jun Lu | www.caina.ltd |
Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd.
Caina Technology Co., Ltd. Fundamentals Summary
| 301122 fundamental statistics | |
|---|---|
| Market cap | CN¥2.35b |
| Earnings (TTM) | CN¥112.56m |
| Revenue (TTM) | CN¥410.47m |
21.4x
P/E Ratio5.9x
P/S RatioIs 301122 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301122 income statement (TTM) | |
|---|---|
| Revenue | CN¥410.47m |
| Cost of Revenue | CN¥250.89m |
| Gross Profit | CN¥159.58m |
| Other Expenses | CN¥47.01m |
| Earnings | CN¥112.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | 0.92 |
| Gross Margin | 38.88% |
| Net Profit Margin | 27.42% |
| Debt/Equity Ratio | 0.009% |
How did 301122 perform over the long term?
See historical performance and comparison